Global Poliomyelitis Vaccines Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Publisher Name :
Date: 20-Sep-2022
No. of pages: 104
Inquire Before Buying

Report Scope

This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Poliomyelitis Vaccines manufacturers, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Poliomyelitis Vaccines market. Further, it explains the major drivers and regional dynamics of the global Poliomyelitis Vaccines market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

- Sanofi

- GSK

- Bibcol

- Serum Institute

- Tiantan Biological

- IMBCA

- Panacea Biotec Ltd

- Bio-Med

- Halfkin Bio-Pharmaceuticals

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.

Poliomyelitis Vaccines Segment by Type

- IPV

- OPV

Poliomyelitis Vaccines Segment by Application

- Research & Academic Laboratories

- Pharmaceutical & Biotechnology Companies

- Others

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - China Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Poliomyelitis Vaccines market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Poliomyelitis Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Poliomyelitis Vaccines, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Poliomyelitis Vaccines, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Poliomyelitis Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Poliomyelitis Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Poliomyelitis Vaccines sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Sanofi, GSK, Bibcol, Serum Institute, Tiantan Biological, IMBCA, Panacea Biotec Ltd, Bio-Med and Halfkin Bio-Pharmaceuticals, etc.

Global Poliomyelitis Vaccines Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Poliomyelitis Vaccines Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 IPV
1.2.3 OPV
1.3 Market Segment by Application
1.3.1 Global Poliomyelitis Vaccines Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Research & Academic Laboratories
1.3.3 Pharmaceutical & Biotechnology Companies
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Poliomyelitis Vaccines Market Size (2017-2028)
2.1.1 Global Poliomyelitis Vaccines Revenue (2017-2028)
2.1.2 Global Poliomyelitis Vaccines Sales (2017-2028)
2.2 Global Poliomyelitis Vaccines Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Poliomyelitis Vaccines Sales by Regions (2017-2022)
2.2.2 Global Poliomyelitis Vaccines Revenue by Regions (2017-2022)
2.3 Global Poliomyelitis Vaccines Market Size Forecast by Region
2.3.1 Global Poliomyelitis Vaccines Sales Forecast by Region (2023-2028)
2.3.2 Global Poliomyelitis Vaccines Revenue Forecast by Region (2023-2028)
2.4 Global Top Poliomyelitis Vaccines Regions (Countries) Ranking by Market Size
2.5 Poliomyelitis Vaccines Market Dynamics
2.5.1 Poliomyelitis Vaccines Market Trends
2.5.2 Poliomyelitis Vaccines Market Drivers
2.5.3 Poliomyelitis Vaccines Market Challenges
2.5.4 Poliomyelitis Vaccines Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Poliomyelitis Vaccines Manufacturers by Sales (2017-2022)
3.1.1 Global Poliomyelitis Vaccines Sales by Manufacturers (2017-2022)
3.1.2 Global Poliomyelitis Vaccines Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Poliomyelitis Vaccines Sales in 2021
3.2 Global Top Manufacturers Poliomyelitis Vaccines by Revenue
3.2.1 Global Poliomyelitis Vaccines Revenue by Manufacturers (2017-2022)
3.2.2 Top Poliomyelitis Vaccines Manufacturers Covered: Ranking by Revenue
3.2.3 Global Poliomyelitis Vaccines Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Poliomyelitis Vaccines Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Poliomyelitis Vaccines as of 2021)
3.4 Global Poliomyelitis Vaccines Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Poliomyelitis Vaccines Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Poliomyelitis Vaccines Market
3.7 Key Manufacturers Poliomyelitis Vaccines Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Poliomyelitis Vaccines Market Size by Type
4.1 Global Poliomyelitis Vaccines Historic Market Review by Type (2017-2022)
4.1.1 Global Poliomyelitis Vaccines Sales Market Share by Type (2017-2022)
4.1.2 Global Poliomyelitis Vaccines Revenue Market Share by Type (2017-2022)
4.1.3 Poliomyelitis Vaccines Price by Type (2017-2022)
4.2 Global Poliomyelitis Vaccines Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Poliomyelitis Vaccines Sales Forecast by Type (2023-2028)
4.2.2 Global Poliomyelitis Vaccines Revenue Forecast by Type (2023-2028)
4.2.3 Poliomyelitis Vaccines Price Forecast by Type (2023-2028)
5 Global Poliomyelitis Vaccines Market Size by Application
5.1 Global Poliomyelitis Vaccines Historic Market Review by Application (2017-2022)
5.1.1 Global Poliomyelitis Vaccines Sales Market Share by Application (2017-2022)
5.1.2 Global Poliomyelitis Vaccines Revenue Market Share by Application (2017-2022)
5.1.3 Poliomyelitis Vaccines Price by Application (2017-2022)
5.2 Global Poliomyelitis Vaccines Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Poliomyelitis Vaccines Sales Forecast by Application (2023-2028)
5.2.2 Global Poliomyelitis Vaccines Revenue Forecast by Application (2023-2028)
5.2.3 Poliomyelitis Vaccines Price Forecast by Application (2023-2028)
6 North America
6.1 North America Poliomyelitis Vaccines Sales Breakdown by Company
6.1.1 North America Poliomyelitis Vaccines Sales by Company (2017-2022)
6.1.2 North America Poliomyelitis Vaccines Revenue by Company (2017-2022)
6.2 North America Poliomyelitis Vaccines Market Size by Type
6.2.1 North America Poliomyelitis Vaccines Sales by Type (2017-2028)
6.2.2 North America Poliomyelitis Vaccines Revenue by Type (2017-2028)
6.3 North America Poliomyelitis Vaccines Market Size by Application
6.3.1 North America Poliomyelitis Vaccines Sales by Application (2017-2028)
6.3.2 North America Poliomyelitis Vaccines Revenue by Application (2017-2028)
6.4 North America Poliomyelitis Vaccines Market Size by Country
6.4.1 North America Poliomyelitis Vaccines Sales by Country (2017-2028)
6.4.2 North America Poliomyelitis Vaccines Revenue by Country (2017-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Poliomyelitis Vaccines Sales Breakdown by Company
7.1.1 Europe Poliomyelitis Vaccines Sales by Company (2017-2022)
7.1.2 Europe Poliomyelitis Vaccines Revenue by Company (2017-2022)
7.2 Europe Poliomyelitis Vaccines Market Size by Type
7.2.1 Europe Poliomyelitis Vaccines Sales by Type (2017-2028)
7.2.2 Europe Poliomyelitis Vaccines Revenue by Type (2017-2028)
7.3 Europe Poliomyelitis Vaccines Market Size by Application
7.3.1 Europe Poliomyelitis Vaccines Sales by Application (2017-2028)
7.3.2 Europe Poliomyelitis Vaccines Revenue by Application (2017-2028)
7.4 Europe Poliomyelitis Vaccines Market Size by Country
7.4.1 Europe Poliomyelitis Vaccines Sales by Country (2017-2028)
7.4.2 Europe Poliomyelitis Vaccines Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Poliomyelitis Vaccines Sales Breakdown by Company
8.1.1 Asia Pacific Poliomyelitis Vaccines Sales by Company (2017-2022)
8.1.2 Asia Pacific Poliomyelitis Vaccines Revenue by Company (2017-2022)
8.2 Asia Pacific Poliomyelitis Vaccines Market Size by Type
8.2.1 Asia Pacific Poliomyelitis Vaccines Sales by Type (2017-2028)
8.2.2 Asia Pacific Poliomyelitis Vaccines Revenue by Type (2017-2028)
8.3 Asia Pacific Poliomyelitis Vaccines Market Size by Application
8.3.1 Asia Pacific Poliomyelitis Vaccines Sales by Application (2017-2028)
8.3.2 Asia Pacific Poliomyelitis Vaccines Revenue by Application (2017-2028)
8.4 Asia Pacific Poliomyelitis Vaccines Market Size by Region
8.4.1 Asia Pacific Poliomyelitis Vaccines Sales by Region
8.4.2 Asia Pacific Poliomyelitis Vaccines Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 China Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
9 Latin America
9.1 Latin America Poliomyelitis Vaccines Sales Breakdown by Company
9.1.1 Latin America Poliomyelitis Vaccines Sales by Company (2017-2022)
9.1.2 Latin America Poliomyelitis Vaccines Revenue by Company (2017-2022)
9.2 Latin America Poliomyelitis Vaccines Market Size by Type
9.2.1 Latin America Poliomyelitis Vaccines Sales by Type (2017-2028)
9.2.2 Latin America Poliomyelitis Vaccines Revenue by Type (2017-2028)
9.3 Latin America Poliomyelitis Vaccines Market Size by Application
9.3.1 Latin America Poliomyelitis Vaccines Sales by Application (2017-2028)
9.3.2 Latin America Poliomyelitis Vaccines Revenue by Application (2017-2028)
9.4 Latin America Poliomyelitis Vaccines Market Size by Country
9.4.1 Latin America Poliomyelitis Vaccines Sales by Country (2017-2028)
9.4.2 Latin America Poliomyelitis Vaccines Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Poliomyelitis Vaccines Sales Breakdown by Company
10.1.1 Middle East and Africa Poliomyelitis Vaccines Sales by Company (2017-2022)
10.1.2 Middle East and Africa Poliomyelitis Vaccines Revenue by Company (2017-2022)
10.2 Middle East and Africa Poliomyelitis Vaccines Market Size by Type
10.2.1 Middle East and Africa Poliomyelitis Vaccines Sales by Type (2017-2028)
10.2.2 Middle East and Africa Poliomyelitis Vaccines Revenue by Type (2017-2028)
10.3 Middle East and Africa Poliomyelitis Vaccines Market Size by Application
10.3.1 Middle East and Africa Poliomyelitis Vaccines Sales by Application (2017-2028)
10.3.2 Middle East and Africa Poliomyelitis Vaccines Revenue by Application (2017-2028)
10.4 Middle East and Africa Poliomyelitis Vaccines Market Size by Country
10.4.1 Middle East and Africa Poliomyelitis Vaccines Sales by Country (2017-2028)
10.4.2 Middle East and Africa Poliomyelitis Vaccines Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Overview
11.1.3 Sanofi Poliomyelitis Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 Sanofi Poliomyelitis Vaccines Products and Services
11.1.5 Sanofi Poliomyelitis Vaccines SWOT Analysis
11.1.6 Sanofi Recent Developments
11.2 GSK
11.2.1 GSK Corporation Information
11.2.2 GSK Overview
11.2.3 GSK Poliomyelitis Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 GSK Poliomyelitis Vaccines Products and Services
11.2.5 GSK Poliomyelitis Vaccines SWOT Analysis
11.2.6 GSK Recent Developments
11.3 Bibcol
11.3.1 Bibcol Corporation Information
11.3.2 Bibcol Overview
11.3.3 Bibcol Poliomyelitis Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 Bibcol Poliomyelitis Vaccines Products and Services
11.3.5 Bibcol Poliomyelitis Vaccines SWOT Analysis
11.3.6 Bibcol Recent Developments
11.4 Serum Institute
11.4.1 Serum Institute Corporation Information
11.4.2 Serum Institute Overview
11.4.3 Serum Institute Poliomyelitis Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 Serum Institute Poliomyelitis Vaccines Products and Services
11.4.5 Serum Institute Poliomyelitis Vaccines SWOT Analysis
11.4.6 Serum Institute Recent Developments
11.5 Tiantan Biological
11.5.1 Tiantan Biological Corporation Information
11.5.2 Tiantan Biological Overview
11.5.3 Tiantan Biological Poliomyelitis Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 Tiantan Biological Poliomyelitis Vaccines Products and Services
11.5.5 Tiantan Biological Poliomyelitis Vaccines SWOT Analysis
11.5.6 Tiantan Biological Recent Developments
11.6 IMBCA
11.6.1 IMBCA Corporation Information
11.6.2 IMBCA Overview
11.6.3 IMBCA Poliomyelitis Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 IMBCA Poliomyelitis Vaccines Products and Services
11.6.5 IMBCA Poliomyelitis Vaccines SWOT Analysis
11.6.6 IMBCA Recent Developments
11.7 Panacea Biotec Ltd
11.7.1 Panacea Biotec Ltd Corporation Information
11.7.2 Panacea Biotec Ltd Overview
11.7.3 Panacea Biotec Ltd Poliomyelitis Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.7.4 Panacea Biotec Ltd Poliomyelitis Vaccines Products and Services
11.7.5 Panacea Biotec Ltd Poliomyelitis Vaccines SWOT Analysis
11.7.6 Panacea Biotec Ltd Recent Developments
11.8 Bio-Med
11.8.1 Bio-Med Corporation Information
11.8.2 Bio-Med Overview
11.8.3 Bio-Med Poliomyelitis Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.8.4 Bio-Med Poliomyelitis Vaccines Products and Services
11.8.5 Bio-Med Poliomyelitis Vaccines SWOT Analysis
11.8.6 Bio-Med Recent Developments
11.9 Halfkin Bio-Pharmaceuticals
11.9.1 Halfkin Bio-Pharmaceuticals Corporation Information
11.9.2 Halfkin Bio-Pharmaceuticals Overview
11.9.3 Halfkin Bio-Pharmaceuticals Poliomyelitis Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.9.4 Halfkin Bio-Pharmaceuticals Poliomyelitis Vaccines Products and Services
11.9.5 Halfkin Bio-Pharmaceuticals Poliomyelitis Vaccines SWOT Analysis
11.9.6 Halfkin Bio-Pharmaceuticals Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Poliomyelitis Vaccines Value Chain Analysis
12.2 Poliomyelitis Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Poliomyelitis Vaccines Production Mode & Process
12.4 Poliomyelitis Vaccines Sales and Marketing
12.4.1 Poliomyelitis Vaccines Sales Channels
12.4.2 Poliomyelitis Vaccines Distributors
12.5 Poliomyelitis Vaccines Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Poliomyelitis Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of IPV
Table 3. Major Manufacturers of OPV
Table 4. Global Poliomyelitis Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Poliomyelitis Vaccines Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 6. Global Poliomyelitis Vaccines Sales by Region (2017-2022) & (K Units)
Table 7. Global Poliomyelitis Vaccines Sales Market Share by Region (2017-2022)
Table 8. Global Poliomyelitis Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 9. Global Poliomyelitis Vaccines Revenue Market Share by Region (2017-2022)
Table 10. Global Poliomyelitis Vaccines Sales Forecast by Region (2023-2028) & (K Units)
Table 11. Global Poliomyelitis Vaccines Sales Market Share Forecast by Region (2023-2028)
Table 12. Global Poliomyelitis Vaccines Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 13. Global Poliomyelitis Vaccines Revenue Market Share Forecast by Region (2023-2028)
Table 14. Top Poliomyelitis Vaccines Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 15. Poliomyelitis Vaccines Market Trends
Table 16. Poliomyelitis Vaccines Market Drivers
Table 17. Poliomyelitis Vaccines Market Challenges
Table 18. Poliomyelitis Vaccines Market Restraints
Table 19. Global Poliomyelitis Vaccines Sales by Manufacturers (2017-2022) & (K Units)
Table 20. Global Poliomyelitis Vaccines Sales Share by Manufacturers (2017-2022)
Table 21. Global Poliomyelitis Vaccines Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 22. Ranking of Global Top Poliomyelitis Vaccines Manufacturers by Revenue (US$ Million) in 2021
Table 23. Poliomyelitis Vaccines Revenue Share by Manufacturers (2017-2022)
Table 24. Global Poliomyelitis Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Poliomyelitis Vaccines as of 2021)
Table 26. Key Manufacturers Poliomyelitis Vaccines Average Selling Price (ASP) & (2017-2022) & (USD/Unit)
Table 27. Key Manufacturers Poliomyelitis Vaccines Plants/Factories Distribution
Table 28. Key Manufacturers Poliomyelitis Vaccines Area Served
Table 29. Date of Key Manufacturers Enter into Poliomyelitis Vaccines Market
Table 30. Key Manufacturers Poliomyelitis Vaccines Product Type
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Poliomyelitis Vaccines Sales (K Units) by Type (2017-2022)
Table 33. Global Poliomyelitis Vaccines Sales Share by Type (2017-2022)
Table 34. Global Poliomyelitis Vaccines Revenue (US$ Million) Market Share by Type (2017-2022)
Table 35. Global Poliomyelitis Vaccines Price (K Units) by Type (2017-2022)
Table 36. Global Poliomyelitis Vaccines Sales (K Units) by Type (2023-2028)
Table 37. Global Poliomyelitis Vaccines Sales Share by Type (2023-2028)
Table 38. Global Poliomyelitis Vaccines Revenue (US$ Million) Market Share by Type (2023-2028)
Table 39. Global Poliomyelitis Vaccines Revenue Share by Type (2023-2028)
Table 40. Global Poliomyelitis Vaccines Price (K Units) by Type (2023-2028)
Table 41. Global Poliomyelitis Vaccines Sales (K Units) by Application (2017-2022)
Table 42. Global Poliomyelitis Vaccines Sales Share by Application (2017-2022)
Table 43. Global Poliomyelitis Vaccines Revenue (US$ Million) Market Share by Application (2017-2022)
Table 44. Global Poliomyelitis Vaccines Price (K Units) by Application (2017-2022)
Table 45. Global Poliomyelitis Vaccines Sales (K Units) by Application (2023-2028)
Table 46. Global Poliomyelitis Vaccines Sales Share by Application (2023-2028)
Table 47. Global Poliomyelitis Vaccines Revenue (US$ Million) Market Share by Application (2023-2028)
Table 48. Global Poliomyelitis Vaccines Revenue Share by Application (2023-2028)
Table 49. Global Poliomyelitis Vaccines Price (K Units) by Application (2023-2028)
Table 50. North America Poliomyelitis Vaccines Sales by Company (2017-2022) & (K Units)
Table 51. North America Poliomyelitis Vaccines Sales Market Share by Company (2017-2022)
Table 52. North America Poliomyelitis Vaccines Revenue by Company (2017-2022) & (US$ Million)
Table 53. North America Poliomyelitis Vaccines Revenue Market Share by Company (2017-2022)
Table 54. North America Poliomyelitis Vaccines Sales by Type (2017-2022) & (K Units)
Table 55. North America Poliomyelitis Vaccines Sales by Type (2023-2028) & (K Units)
Table 56. North America Poliomyelitis Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 57. North America Poliomyelitis Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 58. North America Poliomyelitis Vaccines Sales by Application (2017-2022) & (K Units)
Table 59. North America Poliomyelitis Vaccines Sales by Application (2023-2028) & (K Units)
Table 60. North America Poliomyelitis Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 61. North America Poliomyelitis Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 62. North America Poliomyelitis Vaccines Sales by Country (2017-2022) & (K Units)
Table 63. North America Poliomyelitis Vaccines Sales by Country (2023-2028) & (K Units)
Table 64. North America Poliomyelitis Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 65. North America Poliomyelitis Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 66. Europe Poliomyelitis Vaccines Sales by Company (2017-2022) & (K Units)
Table 67. Europe Poliomyelitis Vaccines Sales Market Share by Company (2017-2022)
Table 68. Europe Poliomyelitis Vaccines Revenue by Company (2017-2022) & (US$ Million)
Table 69. Europe Poliomyelitis Vaccines Revenue Market Share by Company (2017-2022)
Table 70. Europe Poliomyelitis Vaccines Sales by Type (2017-2022) & (K Units)
Table 71. Europe Poliomyelitis Vaccines Sales by Type (2023-2028) & (K Units)
Table 72. Europe Poliomyelitis Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 73. Europe Poliomyelitis Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 74. Europe Poliomyelitis Vaccines Sales by Application (2017-2022) & (K Units)
Table 75. Europe Poliomyelitis Vaccines Sales by Application (2023-2028) & (K Units)
Table 76. Europe Poliomyelitis Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 77. Europe Poliomyelitis Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 78. Europe Poliomyelitis Vaccines Sales by Country (2017-2022) & (K Units)
Table 79. Europe Poliomyelitis Vaccines Sales by Country (2023-2028) & (K Units)
Table 80. Europe Poliomyelitis Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 81. Europe Poliomyelitis Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 82. Asia Pacific Poliomyelitis Vaccines Sales by Company (2017-2022) & (K Units)
Table 83. Asia Pacific Poliomyelitis Vaccines Sales Market Share by Company (2017-2022)
Table 84. Asia Pacific Poliomyelitis Vaccines Revenue by Company (2017-2022) & (US$ Million)
Table 85. Asia Pacific Poliomyelitis Vaccines Revenue Market Share by Company (2017-2022)
Table 86. Asia Pacific Poliomyelitis Vaccines Sales by Type (2017-2022) & (K Units)
Table 87. Asia Pacific Poliomyelitis Vaccines Sales by Type (2023-2028) & (K Units)
Table 88. Asia Pacific Poliomyelitis Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 89. Asia Pacific Poliomyelitis Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 90. Asia Pacific Poliomyelitis Vaccines Sales by Application (2017-2022) & (K Units)
Table 91. Asia Pacific Poliomyelitis Vaccines Sales by Application (2023-2028) & (K Units)
Table 92. Asia Pacific Poliomyelitis Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 93. Asia Pacific Poliomyelitis Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 94. Asia Pacific Poliomyelitis Vaccines Sales by Region (2017-2022) & (K Units)
Table 95. Asia Pacific Poliomyelitis Vaccines Sales by Region (2023-2028) & (K Units)
Table 96. Asia Pacific Poliomyelitis Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 97. Asia Pacific Poliomyelitis Vaccines Revenue by Region (2023-2028) & (US$ Million)
Table 98. Latin America Poliomyelitis Vaccines Sales by Company (2017-2022) & (K Units)
Table 99. Latin America Poliomyelitis Vaccines Sales Market Share by Company (2017-2022)
Table 100. Latin America Poliomyelitis Vaccines Revenue by Company (2017-2022) & (US$ Million)
Table 101. Latin America Poliomyelitis Vaccines Revenue Market Share by Company (2017-2022)
Table 102. Latin America Poliomyelitis Vaccines Sales by Type (2017-2022) & (K Units)
Table 103. Latin America Poliomyelitis Vaccines Sales by Type (2023-2028) & (K Units)
Table 104. Latin America Poliomyelitis Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 105. Latin America Poliomyelitis Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 106. Latin America Poliomyelitis Vaccines Sales by Application (2017-2022) & (K Units)
Table 107. Latin America Poliomyelitis Vaccines Sales by Application (2023-2028) & (K Units)
Table 108. Latin America Poliomyelitis Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 109. Latin America Poliomyelitis Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 110. Latin America Poliomyelitis Vaccines Sales by Country (2017-2022) & (K Units)
Table 111. Latin America Poliomyelitis Vaccines Sales by Country (2023-2028) & (K Units)
Table 112. Latin America Poliomyelitis Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 113. Latin America Poliomyelitis Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 114. Middle East and Africa Poliomyelitis Vaccines Sales by Company (2017-2022) & (K Units)
Table 115. Middle East and Africa Poliomyelitis Vaccines Sales Market Share by Company (2017-2022)
Table 116. Middle East and Africa Poliomyelitis Vaccines Revenue by Company (2017-2022) & (US$ Million)
Table 117. Middle East and Africa Poliomyelitis Vaccines Revenue Market Share by Company (2017-2022)
Table 118. Middle East and Africa Poliomyelitis Vaccines Sales by Type (2017-2022) & (K Units)
Table 119. Middle East and Africa Poliomyelitis Vaccines Sales by Type (2023-2028) & (K Units)
Table 120. Middle East and Africa Poliomyelitis Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 121. Middle East and Africa Poliomyelitis Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 122. Middle East and Africa Poliomyelitis Vaccines Sales by Application (2017-2022) & (K Units)
Table 123. Middle East and Africa Poliomyelitis Vaccines Sales by Application (2023-2028) & (K Units)
Table 124. Middle East and Africa Poliomyelitis Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 125. Middle East and Africa Poliomyelitis Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 126. Middle East and Africa Poliomyelitis Vaccines Sales by Country (2017-2022) & (K Units)
Table 127. Middle East and Africa Poliomyelitis Vaccines Sales by Country (2023-2028) & (K Units)
Table 128. Middle East and Africa Poliomyelitis Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 129. Middle East and Africa Poliomyelitis Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 130. Sanofi Corporation Information
Table 131. Sanofi Description and Overview
Table 132. Sanofi Poliomyelitis Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 133. Sanofi Poliomyelitis Vaccines Product and Services
Table 134. Sanofi Poliomyelitis Vaccines SWOT Analysis
Table 135. Sanofi Recent Developments
Table 136. GSK Corporation Information
Table 137. GSK Description and Overview
Table 138. GSK Poliomyelitis Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 139. GSK Poliomyelitis Vaccines Product and Services
Table 140. GSK Poliomyelitis Vaccines SWOT Analysis
Table 141. GSK Recent Developments
Table 142. Bibcol Corporation Information
Table 143. Bibcol Description and Overview
Table 144. Bibcol Poliomyelitis Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 145. Bibcol Poliomyelitis Vaccines Product and Services
Table 146. Bibcol Poliomyelitis Vaccines SWOT Analysis
Table 147. Bibcol Recent Developments
Table 148. Serum Institute Corporation Information
Table 149. Serum Institute Description and Overview
Table 150. Serum Institute Poliomyelitis Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 151. Serum Institute Poliomyelitis Vaccines Product and Services
Table 152. Serum Institute Poliomyelitis Vaccines SWOT Analysis
Table 153. Serum Institute Recent Developments
Table 154. Tiantan Biological Corporation Information
Table 155. Tiantan Biological Description and Overview
Table 156. Tiantan Biological Poliomyelitis Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 157. Tiantan Biological Poliomyelitis Vaccines Product and Services
Table 158. Tiantan Biological Poliomyelitis Vaccines SWOT Analysis
Table 159. Tiantan Biological Recent Developments
Table 160. IMBCA Corporation Information
Table 161. IMBCA Description and Overview
Table 162. IMBCA Poliomyelitis Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 163. IMBCA Poliomyelitis Vaccines Product and Services
Table 164. IMBCA Poliomyelitis Vaccines SWOT Analysis
Table 165. IMBCA Recent Developments
Table 166. Panacea Biotec Ltd Corporation Information
Table 167. Panacea Biotec Ltd Description and Overview
Table 168. Panacea Biotec Ltd Poliomyelitis Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 169. Panacea Biotec Ltd Poliomyelitis Vaccines Product and Services
Table 170. Panacea Biotec Ltd Poliomyelitis Vaccines SWOT Analysis
Table 171. Panacea Biotec Ltd Recent Developments
Table 172. Bio-Med Corporation Information
Table 173. Bio-Med Description and Overview
Table 174. Bio-Med Poliomyelitis Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 175. Bio-Med Poliomyelitis Vaccines Product and Services
Table 176. Bio-Med Poliomyelitis Vaccines SWOT Analysis
Table 177. Bio-Med Recent Developments
Table 178. Halfkin Bio-Pharmaceuticals Corporation Information
Table 179. Halfkin Bio-Pharmaceuticals Description and Overview
Table 180. Halfkin Bio-Pharmaceuticals Poliomyelitis Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 181. Halfkin Bio-Pharmaceuticals Poliomyelitis Vaccines Product and Services
Table 182. Halfkin Bio-Pharmaceuticals Poliomyelitis Vaccines SWOT Analysis
Table 183. Halfkin Bio-Pharmaceuticals Recent Developments
Table 184. Key Raw Materials Lists
Table 185. Raw Materials Key Suppliers Lists
Table 186. Poliomyelitis Vaccines Distributors List
Table 187. Poliomyelitis Vaccines Customers List
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
List of Figures
Figure 1. Poliomyelitis Vaccines Product Picture
Figure 2. Global Poliomyelitis Vaccines Sales Market Share by Type in 2021 & 2028
Figure 3. IPV Product Picture
Figure 4. OPV Product Picture
Figure 5. Global Poliomyelitis Vaccines Sales Market Share by Application in 2021 & 2028
Figure 6. Research & Academic Laboratories Use Case
Figure 7. Pharmaceutical & Biotechnology Companies Use Case
Figure 8. Others Use Case
Figure 9. Poliomyelitis Vaccines Report Years Considered
Figure 10. Global Poliomyelitis Vaccines Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Poliomyelitis Vaccines Market Size 2017-2028 (US$ Million)
Figure 12. Global Poliomyelitis Vaccines Sales (2017-2022) & (K Units)
Figure 13. Global Poliomyelitis Vaccines Market Size Market Share by Region: 2021 VS 2028
Figure 14. Global Poliomyelitis Vaccines Sales Market Share by Region (2017-2022)
Figure 15. Global Poliomyelitis Vaccines Sales Market Share by Region in 2021
Figure 16. Global Poliomyelitis Vaccines Revenue Market Share by Region in 2017 VS 2021
Figure 17. Global Poliomyelitis Vaccines Sales Share by Manufacturers in 2021
Figure 18. The 5 and 10 Largest Manufacturers in the World: Market Share by Poliomyelitis Vaccines Sales in 2021
Figure 19. Poliomyelitis Vaccines Revenue Share by Manufacturers in 2021
Figure 20. Poliomyelitis Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 21. Global Poliomyelitis Vaccines Revenue Share by Type (2017-2022)
Figure 22. Global Poliomyelitis Vaccines Revenue Growth Rate by Type in 2017 & 2021
Figure 23. Global Poliomyelitis Vaccines Revenue Share by Application (2017-2022)
Figure 24. Global Poliomyelitis Vaccines Revenue Growth Rate by Application in 2017 & 2021
Figure 25. North America Poliomyelitis Vaccines Sales Market Share by Type (2017-2028)
Figure 26. North America Poliomyelitis Vaccines Revenue Market Share by Type (2017-2028)
Figure 27. North America Poliomyelitis Vaccines Sales Market
  • Global Albumin (as Excipient) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 29-Sep-2022        Price: US 5900 Onwards        Pages: 114
    Albumin is a water-soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries. Highlights Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, t......
  • Global Bendamustine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 29-Sep-2022        Price: US 5900 Onwards        Pages: 106
    Bendamustine is a chemotherapy medication used in the treatment of chronic lymphocytic leukemia (CLL), multiple myeloma, and non-Hodgkin's lymphoma. It is given by injection into a vein. Highlights Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Bendamustine market is projected to reach US$ 743.1 million by 2028 from an estimated US$ 784.6 million in 2022, at a CAGR of -0.9% during 2023 and 2028. Market competition is inte......
  • Global Mitomycin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 29-Sep-2022        Price: US 5900 Onwards        Pages: 104
    Mitomycin is an antibiotic which acts as a double-stranded DNA alkylating agent. It covalently crosslinks DNA, inhibiting DNA synthesis and cell proliferation It acts by way of reductive activation either through low pH or NAD(P)H:quinone oxidoreductase (DT-diaphorase) or NADH cytochrome c reductase (Mao et al.; Cummings et al.). Highlights Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Mitomycin market is projected to reach US$......
  • Global Recombinant Human Serum Albumin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 29-Sep-2022        Price: US 5900 Onwards        Pages: 104
    Recombinant Human Serum Albumin (Rec. HSA) is animal origin free expressed in E.coli without animal or human derived raw materials. It is also free from other contaminating serum proteins. Recombinant human serum albumin (rHSA) is genetically engineered and derived from a rice-based expression system. It is a highly purified and completely animal-, virus-, and bacteria-free product that was developed as an alternative to plasma-derived HSA, to which it is structurally equivalent. ......
  • Global Sevoflurane (Sevoflurane Source) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 29-Sep-2022        Price: US 5900 Onwards        Pages: 98
    Sevoflurane is a halogenated general inhalation anesthetic drug. Highlights Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Sevoflurane (Sevoflurane Source) market is projected to reach US$ 1276.4 million by 2028 from an estimated US$ 1315.4 million in 2022, at a CAGR of -0.5% during 2023 and 2028. The top 5 players was expected to reach at about 65% market share by 2020, in terms of the globle sevoflurane revenue. ......
  • Global Iloprost Drugs Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 29-Sep-2022        Price: US 5900 Onwards        Pages: 76
    Iloprost is a drug used to treat pulmonary arterial hypertension (PAH), scleroderma, Raynaud's phenomenon and other diseases in which the blood vessels are constricted and blood can't flow to the tissues. Highlights Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Iloprost Drugs market is projected to reach US$ 80 million by 2028 from an estimated US$ 88 million in 2022, at a CAGR of -1.6% during 2023 and 2028. North Americ......
  • Global Treprostinil Drugs Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 29-Sep-2022        Price: US 5900 Onwards        Pages: 85
    Treprostinil is a vasodilator that is used for the treatment of pulmonary arterial hypertension. Highlights Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Treprostinil Drugs market is projected to reach US$ 1570.4 million by 2028 from an estimated US$ 1292.5 million in 2022, at a CAGR of 3.3% during 2023 and 2028. North America is the largest consumption place, with a consumption market share nearly 92% in 2018. Following......
  • Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 29-Sep-2022        Price: US 5900 Onwards        Pages: 126
    Swine reproductive and respiratory syndrome is an acute and highly contagious viral infection characterized by reproductive disorder and respiratory symptoms in pig population. Highlights Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Swine Reproductive and Respiratory Syndrome Vaccine market is projected to reach US$ 844.2 million by 2028 from an estimated US$ 471.4 million in 2022, at a CAGR of 10.2% during 2023 and 2028.......
  • Global Bio Implant Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 29-Sep-2022        Price: US 5600 Onwards        Pages: 132
    Report Scope This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Bio Implant manufacturers, distributors, end users, industry associations, governments' industry bureaus, industry publicat......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs